Allergy · 1991 · 37 citations · 18 references
Life SciencesPharmacologyPharmacotherapyAllergyClinical PharmacologyHypersensitivityAllergic RhinitisAllergic Rhinitis PharmacotherapyAllergy PharmacotherapyDrug AllergyPollen AllergyRespiratory AllergyAntihistamine PharmacologyAntihistamine TreatmentHistamine Release MeasurementMethacholine Challenge TestMethacholine Challenge TestingNasal Allergen ChallengeNasal SymptomsSeasonal Allergic Rhinitis Treatment
It has been speculated whether the recently developed non-sedating antihistamines may possess other properties than merely being antagonists at the H1-receptors. To investigate this suggestion 12 patients with strictly seasonal allergic rhinitis participated in a double-blind placebo controlled randomized cross-over study outside the pollen season. At steady state levels of 10 mg loratadine, a new non-sedating antihistamine, the patients were challenged with methacholine. This was followed by a nasal challenge with increasing doses of allergen. 24 h later the patients were rechallenged nasally with the same methacholine dose as the day before. The volume of the methacholine-induced nasal secretion was measured and the response to allergen was determined by scoring technique. In returned nasal lavage fluid the levels of histamine and TAME-esterase activity were measured. It was found that loratadine significantly reduced the immediate allergic nasal symptoms compared with placebo (P less than 0.01). Loratadine also reduced the allergen-induced release of histamine into the nasal cavity after the strongest allergen dose, from 9.6 +/- 1.5 (mean +/- SEM) to 6.4 +/- 1.4 ng/ml (P less than 0.05). A similar decrease in the TAME-esterase activity after treatment with loratadine was observed. The TAME-esterase activity decreased from 11.6 *10(3) +/- 2.47 *10(3) to 5.60 *10(3) +/- 1.45 *10(3) CMP (P less than 0.05). There were no significant changes between the active and placebo treatments regarding the methacholine-induced secretory response. This was true for the initial methacholine challenge as well as the secretory response 24 h later.(ABSTRACT TRUNCATED AT 250 WORDS)
18
Inhibitory effect of cetirizine 2HCl on eosinophil migration <i>in vivo</i>
R. Fadel, N. Herpin-Richard, J.‐P. Rihoux et al. · Clinical & Experimental Allergy · 1987 · 197 citations
Peter Borum · Journal of Allergy and Clinical Immunology · 1979 · 148 citations
C. R. Baumgarten, R C Nichols, Robert M. Naclerio et al. · The Journal of Immunology · 1986 · 105 citations · Full text
Antiallergic activity of H1-receptor antagonists assessed by nasal challenge
Jean Bousquet, B. Lebel, I. Chanal et al. · Journal of Allergy and Clinical Immunology · 1988 · 104 citations
Medicine, Immunology, Pharmacology +10